Growth hormone promotes height growth, but it is only indicated for patients with growth hormone deficiency and has a therapeutic effect on patients with dwarfism. If the patient’s growth hormone level is normal, the use of exogenous growth hormone will not be able to provide this kind of therapeutic effect. Growth hormone has growth-promoting effects in the human body, such as promoting protein synthesis, bone deposition, and the growth of internal organs. Therefore, it has an important growth-promoting effect on children during their growth period. Some children may have insufficient secretion of growth hormone due to genetic factors, or due to brain damage, or due to acquired factors such as infection, resulting in a significant reduction in the patient’s height relative to normal children. If exogenous growth hormone can be supplemented in time, the patient’s height will be restored to normal, i.e. normal development. However, if timely intervention is not made, dwarfism, or shortness of stature, can result. If the hormone levels in the patient’s body are normal, supplementation with such hormones will not make the patient grow taller, regardless of whether he or she is in a growth spurt or not.